MR-axillography oriented surgical sampling for assessment of nodal status in the selection of patients with breast cancer for axillary lymph nodes dissection

Breast Cancer

Volumn 9, Issue 1, 2002, Pages 69-74

  Suzuma, Takaomi ^a   Sakurai, Takeo ^a   Yoshimura, Goro ^a   Umemura, Teiji ^a   Tamaki, Takeshi ^a   Yang, Qi Feng ^a   Oura, Shoji ^a   Naito, Yasuaki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; MR axillography; Surgical sampling

Indexed keywords

ADULT; AGED; ARTICLE; AXILLA; BREAST TUMOR; EVALUATION; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTION AND FORECASTING; RADIOGRAPHY; SENTINEL LYMPH NODE BIOPSY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENTINEL LYMPH NODE BIOPSY;

EID: 0036052683     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967550     Document Type: Article

References (37)

1. Davies GC, Millis RS, Hayward JL: Assessment of axillary lymph node status. Ann Surg 192:148-151, 1980. (Pubitemid 10034331)
2. Bonnema J, van Geel AN, van Ooijen B, et al: Ultrasound-Guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg 21:270-274, 1997. (Pubitemid 27100487)
3. March DE, Wechsler RJ, Kurtz AB, et al: CT-pathologic correlation of axillary lymph nodes in breast carcinoma. J comput Assist Tomogr 15:440-444, 1991.
4. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822, 1996. (Pubitemid 26406231)
5. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391401, 1999.
6. Krag D, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 339:941-946, 1998. (Pubitemid 28455095)
7. Veronesi U, Paganelli G, Galimberti V, et al: Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864-1867, 1997. (Pubitemid 27270119)
8. Fisher CJ, Boyle S, Burke M, et al: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 80:457-458, 1993. (Pubitemid 23116082)
9. Forrest APM, Roberts MM, Cant F, et al: Simple mastectomy and pectoral node biopsy. Br J Surg 63:569-575, 1976.
10. Greenall MJ: Why I favour axillary node sampling in the management of breast cancer. Eur J Surg Oncol 21:2-5, 1995.
11. Kjaergaard J, Blichert-Toft M, Andersen JA, et al: Pedersen BV and the Danish Breast Cancer Co-operative Group: Breast cancer: Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br J Surg 72:365-367, 1985. (Pubitemid 15034707)
12. Steele RJC, Forrest APM, Gibson T, et al: The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer; a controlled randomized trial. Br J Surg 72:368-369, 1985. (Pubitemid 15034708)
13. Forrest APM, Everington D, McDonald CC, et al: The Edinburgh randomized trial of axillary sampling or clearance after mastectomy. Br J Surg 82:1504-1508, 1995.
14. Kingston RD, Bridger J, Smith CJ, et al: Axillary sampling and radiotherapy does not compromise the patient with early breast cancer: Trafford database experience. Eur J Surg Oncol 21:364-367, 1995.
15. Blichert-Toft M, Smola MG, Cataliotti L, et al: Principles and guidelines for surgeons-management of symptomatic breast cancer. On behalf of the European Society of Surgical Oncology. Eur J Surg Oncol 23:101-9, 1997. (Pubitemid 27223001)
16. The Breast Surgeons Group of the British Association of Surgical Oncology: Guidelines for surgeons in the management of symptomatic breast disease in the United Kingdom. Eur J Surg Oncol 21(Suppl A):1-13, 1995.
17. NIH Consensus Development Conference. NIH-Consensus Statement 8:1-19, 1992.
18. Hergan K, Morrigl B, Kathrein A, et al: MR and CT anatomy of the axilla. Acta Radiologica 38:198-205, 1997. (Pubitemid 127452629)
19. Yoshimura G, Sakurai T, Oura S, et al: Evaluation of axillary lymph node status in breast cancer with MRI. Breast Cancer 6:249-258, 1999.
20. Fleming ID, Cooper JS, Henson DE, et al, editors: American Joint Committee on Cancer Staging Manual, 5th ed, JB Lippincott Co, Philadelphia, pp171-180, 1997.
21. Kissin MW, Thompson EM, Price AB, et al: The inadequacy of axillary sampling in breast cancer. Lancet I 8283:1210-2, 1982.
22. Kichen P, MacLennan R, Mursell A: Node-positive breast cancer: a comparison of clinical and pathological findings and assessment of axillary clearance. Aust N Z J Surg 50:580-583, 1980. (Pubitemid 11163064)
23. Pigott J, Nichols R, Maddox W, et al: Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures. Surg Gynecol Obstet 158:255-259, 1984. (Pubitemid 14161079)
24. Sacre R: Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol 12:169-173, 1986. (Pubitemid 16011037)
25. Cserini G: Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer. Pathol Oncol Res 5:129-133, 1999.
26. Day MJ: Expression of interleukin-1 beta, interlerkin-6 and tumour necrosis factor alpha by macrophages in canine lymph nodes with mineral-associated lymphadenopathy, granulomatous lymphadenitis or reactive hyperplasia. J Comp Pathol 114:31-42, 1996. (Pubitemid 26121752)
27. Suzuma T, Sakurai T, Yoshimura G, et al: A mathematical model of axillary lymph node involvement considering lymph node size in patients with breast cancer. Cancer 8:206-212, 2001.
28. Cabanas RM: An approach for the treatment of penile cancer. Cancer 39:456-466, 1977.
29. Weaver DL, Krag DN, Ashikaga T, et al: Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma. Cancer 88:1099-1107, 2000. (Pubitemid 30127672)
30. Cox CE, Pendas S, Cox JM, et al: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645-653, 1998. (Pubitemid 28530914)
31. Noguchi M, Motomura K, Imoto S, et al: A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 63:3140, 2000.
32. Turner RR, Ollila DW, Krasne DL, et al: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226:271-278, 1997. (Pubitemid 28070919)
33. Macmillan RD, Barbera D, Hadjiminas DJ, et al: Sentinel node biopsy for breast cancer may have little to offer four-node-samplers: results of a prospective comparison study. Eur J Cancer 37:1076-1080, 2001.
34. Fisher B, Montague E, Redmond C: Comparison of radical mastectomy with alternative treatments for primary breast cancer: a first report of results from prospective randomized clinical trial. Cancer 29:2827-2839, 1977. (Pubitemid 8130398)
35. Fisher B, Redmond C, Fisher E: Ten-year results of randomized trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674-681, 1985. (Pubitemid 15134703)
36. Baum M, Coyle PJ: Simple mastectomy for early breast cancer and the behavior of the untreated axillary nodes. Bull Cancer 218:603-610, 1977. (Pubitemid 8245619)
37. Chetty U, Jack W, Prescott RJ, et al: on behalf of the Edinburgh Breast Unit: Management of the axilla in operable breast cancer treated by conservation: a randomized clinical trial. Br J Surg 87:163-169, 2000. (Pubitemid 30088642)